The information contained in this page is intended for UK healthcare professionals only.
NUMETA G13%E is the only triple-chamber, licensed and terminally sterilised, ready-to-use parenteral nutrition product available to treat preterm infants who are at high risk for infection and malnutrition in the early hours and days of their lives.
NUMETA G13%E is formulated to follow the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and The European Society of Clinical Nutrition and Metabolism (ESPEN) guidelines to meet neonatal nutritional needs with a balanced formulation of amino acids (protein), glucose (carbohydrates), lipids (fats) and electrolytes.
NUMETA is also available in additional formulations, including NUMETA G16%E
500mL for full term infants through two years of age, and NUMETA G19%E 1,000mL for children and adolescents (2-18 years of age).
NUMETA G13%E is industrially prepared, lowering the risk of medication errors and infection associated with custom compounding1,2
NUMETA is flexible to meet patient needs day by day
Activate the lipid chamber only as needed
Add other ingredients as needed
Available for immediate nutritional support, with stability to store at room temperature